| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5069d5d652789ee4bfe9326c7725ecd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-60 |
| filingDate |
2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb96995c1358916964bedf00b7e7eee4 |
| publicationDate |
2020-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2799309-T3 |
| titleOfInvention |
Compounds and compositions for the treatment of multiple sclerosis |
| abstract |
Compound of Formula II: ** (See formula) ** or a pharmaceutically acceptable salt or a stereoisomer thereof; wherein, R1 and R3 are each independently absent; R2 is ** (See formula) ** and R4 is selected from ** (See formula) ** |
| priorityDate |
2014-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |